{"id":"NCT01089127","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)","officialTitle":"A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Different Doses of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease, Using Salmeterol as an Active Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2010-07","completion":"2010-07","firstPosted":"2010-03-18","resultsPosted":"2011-08-19","lastUpdate":"2011-08-19"},"enrollment":552,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"Indacaterol","otherNames":[]},{"type":"DRUG","name":"Salmeterol 50 μg","otherNames":[]},{"type":"DRUG","name":"Placebo to indacaterol","otherNames":[]},{"type":"DRUG","name":"Placebo to salmeterol","otherNames":[]}],"arms":[{"label":"Indacaterol 18.75 μg","type":"EXPERIMENTAL"},{"label":"Indacaterol 37.5 μg","type":"EXPERIMENTAL"},{"label":"Indacaterol 75 μg","type":"EXPERIMENTAL"},{"label":"Indacaterol 150 μg","type":"EXPERIMENTAL"},{"label":"Salmeterol 50 μg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study compared the 14-day bronchodilator efficacy of indacaterol with that of placebo and salmeterol.","primaryOutcome":{"measure":"Trough Forced Expiratory Volume in 1 Second (FEV1) 24 Hours Post-dose at the End of the Study (Week 2 + 1 Day, Day 15)","timeFrame":"24 hours post-dose at the end of the study (Week 2 + 1 day, Day 15)","effectByArm":[{"arm":"Indacaterol 18.75 μg","deltaMin":1.35,"sd":0.02},{"arm":"Indacaterol 37.5 μg","deltaMin":1.38,"sd":0.019},{"arm":"Indacaterol 75 μg","deltaMin":1.38,"sd":0.019},{"arm":"Indacaterol 150 μg","deltaMin":1.4,"sd":0.019},{"arm":"Salmeterol 50 μg","deltaMin":1.39,"sd":0.019},{"arm":"Placebo","deltaMin":1.28,"sd":0.019}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":7},"locations":{"siteCount":69,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":89},"commonTop":["Cough","Vomiting","Blood creatine phosphokinase increased","Headache","Dermatitis contact"]}}